14-3-3ε has no homology to LIS1 and lies telomeric to it on chromosome 17p13.3 outside the Miller-Dieker syndrome chromosome region

Genome Research

Volumn 6, Issue 8, 1996, Pages 735-741

  Chong, Samuel S ^a,b   Tanigami, Akira ^a   Roschke, Anna V ^a   Ledbetter, David H ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA;

ANIMAL CELL; ARTICLE; BRAIN MALFORMATION; CHROMOSOME 17P; CONTROLLED STUDY; DNA PROBE; DNA SEQUENCE; DNA TRANSCRIPTION; GENE ISOLATION; GENE LOCATION; GENE MAPPING; HUMAN; HUMAN CELL; MILLER DIEKER SYNDROME; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SHEEP; TELOMERE; TUMOR SUPPRESSOR GENE;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; 14-3-3 PROTEINS; ABNORMALITIES, MULTIPLE; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; CLONING, MOLECULAR; DNA, COMPLEMENTARY; HUMANS; MICE; MICROTUBULE-ASSOCIATED PROTEINS; MOLECULAR SEQUENCE DATA; PROTEINS; RATS; SEQUENCE ANALYSIS; SHEEP; SYNDROME; TELOMERE; TYROSINE 3-MONOOXYGENASE;

ACRONICTA LEPORINA; ANIMALIA; OVIS ARIES;

EID: 0029738794     PISSN: 10549803     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Aitken, A. 1995. 14-3-3 proteins on the MAP. Trends Biochem. Sci. 20: 95-97.
2. Aitken, A., D. Jones, Y. Soneji, and S. Howell. 1995. 14-3-3 proteins: Biological structure and domain structure. Biochem. Soc. Trans. 23: 605-611.
3. Altschul, S.F., W. Gish, W. Miller, E.W. Myers, and D.J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215: 403-410.
4. Biegel, J.A., C.D. Burk, F.G. Barr, and B.S. Emanuel. 1992. Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors. Cancer Res. 52: 3391-3395.
5. Burbelo, P.D. and A. Hall. 1995. 14-3-3 proteins: Hot numbers in signal transduction. Curr. Biol. 5: 95-96.
6. Cogen, P.H., L. Daneshvar, A.K. Metzger, G. Duyk, M.S.B. Edwards, and V.C. Sheffield. 1992. Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis. Am. J. Hum. Genet. 50: 584-589.
7. Conklin, D.S., K. Galaktionov, and D. Beach. 1995. 14-3-3 proteins associate with cdc25 phosphatases. Proc. Natl. Acad. Sci. 92: 7892-7896.
8. Dobyns, W.B. 1987. Developmental aspects of lissencephaly and the lissencephaly syndromes. Birth Defects Orig. Artic. Ser. 23: 225-241.
9. Dobyns, W.B., O. Reiner, R. Carrozzo, and D.H. Ledbetter. 1993. Lissencephaly, a human brain malformation associated with deletion of the LIS1 gene located at chromosome 17p13. J. Am. Med. Assoc. 270: 2838-2842.
10. Ford, J.C., F. Al-Khodairy, E. Fotou, K.S. Sheldrick, D.J.F. Griffiths, and A.M. Carr. 1994. 14-3-3 protein homologs required for the DNA damage checkpoint in fission yeast. Science 265: 533-535.
11. Galaktionov, K., A.K. Lee, J. Eckstein, G. Draetta, J. Meckler, M. Loda, and D. Beach. 1995a. CDC25 phosphatases as potential human oncogenes. Science 269: 1575-1577.
12. Galaktionov, K., C. Jessus, and D. Beach. 1995b. Raf1 interaction with cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation. Genes & Dev. 9: 1046-1058.
13. Gelperin, D., J. Weigle, K. Nelson, P. Roseboom, K. Irie, K. Matsumoto, and S. Lemmon. 1995. 14-3-3 proteins: Potential roles in vesicular transport and Ras signaling in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. 92: 11539-11543.
14. Ledbetter, D.H., S.A. Ledbetter, P. vanTuinen, K.M. Summers, T.J. Robinson, Y. Nakamura, R. Wolff, R. White, D.F. Barker, M.R. Wallace, F.S. Collins, and W.B. Dobyns. 1989. Molecular dissection of a contiguous gene syndrome: Frequent submicroscopic deletions, evolutionarily conserved sequences, and a hypomethylated "island" in the Miller-Dieker chromosome region. Proc. Natl. Acad. Sci. 86: 5136-5140.
15. McConnell, J.E., J.F. Armstrong, P.E. Hodges, and J.B. Bard. 1995. The mouse 14-3-3 epsilon isoform, a kinase regulator whose expression pattern is modulated in mesenchyme and neuronal differentiation. Dev. Biol. 169: 218-228.
16. McDonald, J.D., L. Daneshvar, J.R. Willert, K. Matsumura, F. Waldman, and P.H. Cogen. 1994. Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in medulloblastoma. Genomics 23: 229-232.
17. Millar, J.B. and P. Russell. 1992. The cdc25 M-phase inducer: An unconventional protein phosphatase. Cell 68: 407-410.
18. Morris, C., S. Benjes, L. Haataja, D.H. Ledbetter, N. Heisterkamp, and J. Groffen. 1995. Spatial organization of ABR and CRK genes on human chromosome band 17p13.3. Oncogene 10: 1009-1011.
19. Morrison, D. 1994. 14-3-3: Modulators of signalling proteins? Science 266: 56-57.
20. Muslin, A.J., J.W. Tanner, P.M. Allen, and A.S. Shaw. 1996. Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 84: 889-897.
21. Nagai, M.A., A.C. Medeiros, M.M. Brentani, R.R. Brentani, L.A. Marques, S. Mazoyer, and L.M. Mulligan. 1995. Five distinct deleted regions on chromosome 17 defining different subsets of human primary breast tumors. Oncology 52: 448-453.
22. Phillips, N., M. Ziegler, B. Saha, and F. Xynos. 1993. Allelic loss on chromosome 17 in human ovarian cancer. Int. J. Cancer 54: 85-91.
23. Reiner, O., R. Carrozzo, Y. Shen, M. Wehnert, F. Faustinella, W.B. Dobyns, C.T. Caskey, and D.H. Ledbetter. 1993. Isolation of a Miller-Dieker lissencephaly gene containing G protein β-subunit-like repeats. Nature 364: 717-721.
24. Reiner, O., I. Bar-Am, T. Sapir, O. Shmueli, R. Carrozzo, E.A. Lindsay, A. Baldini, D.H. Ledbetter, and A. Cahana. 1995. LIS2, gene and pseudogene, homologous to LIS1 (Lissencephaly 1), located on the short and long arms of chromosome 2. Genomics 30: 251-256.
25. Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular cloning: A laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
26. Saxena, A., W.C. Clark, J.T. Robertson, B. Ikejiri, E.H. Oldfield, and I.U. Ali. 1992. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas. Cancer Res. 52: 6716-6721.
27. Stack, M., D. Jones, G. White, D.S. Liscia, T. Venesio, G. Casey, D. Crichton, J. Varley, E. Mitchell, J. Heighway, and M. Santibanez-Koref. 1995. Detailed mapping and loss of heterozygosity analysis suggests a suppressor locus involved in sporadic breast cancer within a distal region of chromosome band 17p13.3. Hum. Mol. Genet. 4: 2047-2055.
28. vanTuinen, P., D.C. Rich, K.M. Summers, and D.H. Ledbetter. 1987. Regional mapping panel for human chromosome 17: Application to neurofibromatosis type 1. Genomics 1: 374-381.
29. Wales, M.M., M.A. Biel, W. El-Deiry, B.D. Nelkin, J-P. Issa, W.K. Cavenee, S.J. Kuerbitz, and S.B. Baylin. 1995. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nature Med. 1: 570-577.
30. Williamson, M.P., P.A. Elder, and M.A. Knowles. 1994. The spectrum of TP53 mutations in bladder carcinoma. Genes Chromosomes Cancer 9: 108-118.